1α,25-dihydroxyvitamin-D3, 213
α1-proteinase inhibitor, 279
activation-induced cell death, 255, 436
acute, 398
ADCC, 88
AECA, 187
aetiology, 511
age, 110
allergic reactions, 124
allergy, 398
alveolar macrophage, 313
alveolitis, 3
ANCA, 187, 347
animal model, 44, 411
antibody, 27, 169
antibody affinity, 555
antibody formation, 429
anti-E3 antibody, 347
antimitochondrial antibodies, 83
anti-proteinase 3, 347
anti-tumour immunity, 204
apicomplexans, 416
apoptosis susceptibility, 421
apoptosis, 21, 88, 175, 255
asthma, 295
atopy, 398
autoantibody, 498, 511, 555
autoimmune diabetes recurrence, 213
autoimmunity, 75, 302, 353, 395, 498
B cell activation, 308
B cell clone, 436
B lymphocytes, 429
β2-microglobulin, 27
BALB/c mouse, 245
bare lymphocyte syndrome, 525
BCG, 52
BCG infection, 405
Bcl-2 family, 436
bcl-xL, 21
biosensor, 555
bladder cancer, 52
bone metabolism, 532
Caco-2 cells, 279
cancer-associated retinopathy, 498
CAR, 498
caspase 3, 267
CCR6, 548
CD14, 275, 326, 444
CD163, 275
CD28, 339, 429
CD4, 359
CD4 cells, 155
CD4+ T cells, 204
CD4+ T lymphocyte, 195
CD40, 308
CD40 ligand, 416
CD45RO, 339
CD56+ T cells, 453
CD57+ T cells, 453
CD8, 339
CD8+ T cell, 10
CD8+ T lymphocyte, 195
cell mediated immunity, 140
cerebrospinal fluid, 379
chemokine, 285
chemokine receptor, 285
children, 365
cholangitis, 416
chronic, 398
connective tissue disease, 102
cornea, 67
corticosteroid, 21
CpG ODN, 467
CPPS, 302
CTLpf, 388
cyclic AMP, 460
cycling of peptide recognition, 538
cyclophilin, 124
cyclophosphamide, 181, 255
cytochrome c, 267
cytokine balance, 110
cytokine imbalances, 421
cytokines, 59, 94, 229, 238, 279, 295, 333, 460, 504, 562
cytotoxicity, 52
deficiency, 525
dendritic cells, 1, 118, 379, 504
diagnosis, 140
disease activity, 187
E. granulosus, 124
encephalomyelitis, 245
endothelial cell, 187
engineered antibody fragment, 67
enterocyte antibodies, 88
eosinophils, 483
eotaxin, 483
epitope, 195
epitope immunodominance, 538
Epstein-Barr virus, 525
experimental autoimmune matrix metalloproteinases, 245
F. nucleatum, 238
FACS, 532
farmer’s lung, 3
Fas/FasL system, 88
flavoprotein, 83
flow cytometry, 295, 490
gangliosides, 27
gene expression, 59
gene knockout mice, 27
geohelminth, 398
glomerular basement membrane, 555
glomerulonephritis, 36, 429
Goodpasture’s disease, 555
granuloma, 525
Graves’ disease, 308
HAART, 365
haemorrhagic fever, 163
HCV, 195, 353
heart transplant, 175
heat shock proteins, 318
Heliobacter pylori, 326
hepatitis C virus, 347
HERV-K, 75
histones, 175
HIV, 155, 365
HIV-1, 359
HLA, 195
host resistance models, 405
HTLpf, 388
human, 163
human mesangial cell, 285
human monocyte, 275
human placental lactogen, 275
hypo-osmotic shock, 59
idiopathic pulmonary fibrosis, 169
IgA autoantibodies, 102
IgE, 124, 562
IgG, 204, 359
IgG4, 124
IgG autoantibodies, 102
IL-1β, 221
IL-10, 36, 163, 308, 516
IL-12, 181, 308, 453, 516
IL-13, 532
IL-18, 516
IL-4, 308, 532
IL-8, 110
immune escape, 195
immunodeficiency diseases, 532
immunodeficiency, 131, 416
immunoglobulin-secreting cell, 10
immunohistochemistry, 94
immunomodulators, 474
immunopathogenesis, 372
immunophenotyping, 149
immunoprotection, 411
immunoregulation, 398
immunosenescence, 110
immunosuppression, 204
immunosuppressive drugs, 255
immunotherapeutics, 67
immunotherapy, 395
in situ hybridization, 94
in situ PCR, 229
infant and adult blood, 490
infants, 313
inflammation, 44
inflammatory bowel disease, 279
influenza, 339
innate immunity, 163
iNOS, 467
interferon-beta, 213
interferon-gamma, 10, 110, 140, 405, 453, 516
intracellular cytokine production, 490
islet transplantation, 213
kinetic response assay, 538
latent tuberculosis, 229
leprosy, 333
leptin, 21
lipopolysaccharide, 221, 444
LPS, 1, 118
lung inflammation, 3
lupus, 75
Lyme disease, 379
lymphocyte, 149
lymphocyte proliferation, 359
lymphocyte trafficking, 44
lymphopenia, 339
M. leprae, 140
macrophage, 36, 52, 59, 279
maturation, 118
MCP-1, 285
meningitis, 379
mesangial cell, 36
methotrexate, 255
MHC class I, 27
mice, 405
microarray, 474
MIF, 504
MIP-3α, 548
mitochondria, 436
mitochondrial antigen, 83
mitochondrial membrane potential, 267
mitochondrial permeability transition, 267
MLC, 388
monoclonal antibody, 44
monocyte, 163, 444
monocytes/macrophages, 474
mouse macrophage, 467
mouse model, 238
MRC5, 169
mRNA, 94
multidrug-resistant pulmonary tuberculosis, 516
multiple myeloma, 131
multiple sclerosis, 379, 395, 538
Mycobacterium tuberculosis, 149
myelin basic protein, 395, 538
myocarditis, 83
neonatal, 1, 118
nephritis, 285
nerve damage, 333
NF-κB, 483
nitric oxide, 467
non-specific interstitial pneumonia, 169
oestrogen, 10
opportunistic infections, 155
oral ulcers, 318
P. gingivalis, 238
p38 MAPK, 483
paraneoplasm, 498
peptide transporter, 525
peptides, 140, 318
perforin, 88
periodontal disease, 548
peripheral blood B cells, 353
phosphodiesterase, 460
pigeon fancier’s lung, 3
plasma-free blood activation assay, 490
Pneumocystis carinii, 155
pneumonitis, 3
polymorphism, 326
potential coeliac disease, 94
PPD antigen, 516
progesterone, 10
prospective, 511
prostaglandin E2, 52
prostatitis, 302
protein C receptor, 187
proteinase-3, 444
quantitative bacteraemia, 411
reaction, 333
reactive oxygen species, 436
retinochoroiditis, 372
rheumatoid arthritis, 44, 75
rheumatoid factor, 347
rotavirus, 511
S. pneumoniae, 411
seminal plasma, 302
Sjogren’s syndrome, 75, 562
soluble TNFR1, 175
sonicated adjuvant, 245
specific antibodies, 238
spectratyping, 155
staphylococcal enterotoxin A, 453
Staphylococcus aureus, 131
succinate dehydrogenase, 83
superantigen, 131
suppression, 313
T cell, 405, 460
T cell function, 365
T cell receptor, 155
T cell repertoire, 395
T cell subsets, 94
T lymphocytes, 110, 175, 313, 429, 490, 562
T. cruzi, 421
tapering immunosuppression, 388
TCR, 295
TGF-β, 204, 372
Th1/Th2, 1, 118
Th1/Th2 balance, 562
thrombomodulin, 187
thymus atrophy, 421
tissue inhibitors of matrix metalloproteinases, 245
TLC immunostaining, 27
TNF, 483
TNF-α, 181, 444
Tnfrsf, 416
tolerance, 221
toxic shock syndrome, 131
Toxoplasma gondii, 372
tributyltin, 267
tuberculosis, 149
type 1 diabetes, 213, 511
ulcerative colitis, 504
vasculitis, 187
vimentin, 169
viral load, 359
Wegener’s granulomatosis, 181, 187